Kiniksa Pharmaceuticals (KNSA)
(Delayed Data from NSDQ)
$25.64 USD
-0.61 (-2.32%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $25.67 +0.03 (0.12%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Company Summary
Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.
Company Summary
General Information
Kiniksa Pharmaceuticals, Ltd
23 Old Bond Street Floor 3
London, X0 WIS 4PZ
Phone: 781-431-9100
Fax: NA
Email: ir@kiniksa.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 10/29/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.01 |
Current Year EPS Consensus Estimate | -0.29 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 10/29/2024 |